These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease. Gershon AS; Wang L; To T; Luo J; Upshur RE COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148 [TBL] [Abstract][Full Text] [Related]
27. Adenosine A(2A) agonists as therapy for glomerulonephritis. Ferenbach DA; Hughes J Kidney Int; 2011 Aug; 80(4):329-31. PubMed ID: 21799503 [TBL] [Abstract][Full Text] [Related]
28. The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study. Man SF; Xuekui Zhang ; Vessey R; Walker T; Lee K; Park D; Sin DD Ther Adv Respir Dis; 2009 Apr; 3(2):73-80. PubMed ID: 19465442 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and SAR studies of trisubstituted purinones as potent and selective adenosine A2A receptor antagonists. Shao Y; Cole AG; Brescia MR; Qin LY; Duo J; Stauffer TM; Rokosz LL; McGuinness BF; Henderson I Bioorg Med Chem Lett; 2009 Mar; 19(5):1399-402. PubMed ID: 19181527 [TBL] [Abstract][Full Text] [Related]
30. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Sobieraj DM; White CM; Coleman CI Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985 [TBL] [Abstract][Full Text] [Related]
31. Regulation of somatostatin release by adenosine in the mouse stomach. Yang GK; Chen JF; Kieffer TJ; Kwok YN J Pharmacol Exp Ther; 2009 May; 329(2):729-37. PubMed ID: 19208896 [TBL] [Abstract][Full Text] [Related]
32. [Pneumology. Should we fear inhaled anticholinergic bronchodilators?]. Rochat T; Janssens JP Rev Med Suisse; 2009 Jan; 5(186):135-7. PubMed ID: 19238933 [TBL] [Abstract][Full Text] [Related]
33. Changes in intracellular cyclic AMP formation mask opposing modulation of kainate-enhanced glutamate release in the striatum. Dohovics R; Janáky R; Varga V; Saransaari P; Oja SS Proc West Pharmacol Soc; 2004; 47():35-8. PubMed ID: 15633607 [No Abstract] [Full Text] [Related]
34. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304 [TBL] [Abstract][Full Text] [Related]
35. Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease. Black PN; McDonald CF Postgrad Med J; 2009 Mar; 85(1001):141-7. PubMed ID: 19351641 [TBL] [Abstract][Full Text] [Related]
37. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study. Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359 [TBL] [Abstract][Full Text] [Related]
38. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking. Kiri VA; Fabbri LM; Davis KJ; Soriano JB Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832 [TBL] [Abstract][Full Text] [Related]
39. A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines. van Veldhoven JP; Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Struensee-Link R; Beukers MW; Brussee J; IJzerman AP Bioorg Med Chem; 2008 Mar; 16(6):2741-52. PubMed ID: 18258439 [TBL] [Abstract][Full Text] [Related]
40. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Singh S; Amin AV; Loke YK Arch Intern Med; 2009 Feb; 169(3):219-29. PubMed ID: 19204211 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]